A Microchip for High-throughput Axon Growth Drug Screening.
Ontology highlight
ABSTRACT: It has been recently known that not only the presence of inhibitory molecules associated with myelin but also the reduced growth capability of the axons limit mature central nervous system (CNS) axonal regeneration after injury. Conventional axon growth studies are typically conducted using multi-well cell culture plates that are very challenging to investigate localized effects of drugs and limited to low throughput. Unfortunately, there is currently no other in vitro tools that allow investigating localized axonal responses to biomolecules in high-throughput for screening potential drugs that might promote axonal growth. We have developed a compartmentalized neuron culture platform enabling localized biomolecular treatments in parallel to axons that are physically and fluidically isolate
SUBMITTER: Kim HS
PROVIDER: S-EPMC5137948 | biostudies-literature | 2016 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA